FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/11/2023
Voltar para busca
Dado oficial do USPTO
THE PHARM BIO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
12/11/2023
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
36, 44, 45
Data de depósito
10/09/2021
Data de registro
04/07/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
04/07/2023
Última transação
04/07/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
Parkville VIC 3052, AU
Examinador
JARAMILLO, JAVIER R
Unidade examinadora
M70
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of an incomplete hexagon above and intersecting another incomplete hexagon. A short, rounded line segment extends downward from the lowest vertex of the lower hexagon. To the right of this design appears the wording "THE PHARM BIO" in stylized font.
Titulares e representantes
Titulares
The Pharm Bio Pty Ltd as trustee for The
The Pharm Bio Pty Ltd as trustee for ThePharm Bio Unit Trust
SYNthesis Research Pty Ltd
Representantes
Neil B Friedman Hodgson Russ LLP
Classificação técnica
Classes Nice
Classe 36Classe 44Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 36
Financial services, namely, capital investment; funds management, namely, management of a capital investment fund; venture capital financing; venture capital fund management; investment services, namely, asset acquisition for financial investment; investment of funds for others; commercial property investment services, namely, investment of funds for others in the field of commercial property; capital investment in real estate; trustee services, namely, investment trusteeship; trust investment services, namely, investment and trust company services; investment management; financial investment custody services, namely, maintaining possession of financial assets for others for financial management purposes; financial portfolio management; financial investment fund services, namely, investment of funds for others; trading in stocks; advancement of funds, namely, cash advance services for businesses and merchants; capital investment; financial services, namely, commodity trading for others; financial services, namely, investment asset management; financial services, namely, financial portfolio management; project financing; financing services; financial advisory services; financial consultancy; financial information services; investment advice; financial analysis, namely, investment analysis; providing investment information; financial research, namely, investment research; provision and funding of educational scholarships; advisory and consultancy services relating to the aforementioned services
Classe 44
Medical advisory services relating to pharmaceutical products; pharmaceutical advisory services; provision of medical information relating to pharmaceuticals; consultancy and advisory services in relation to medical services; consultancy relating to health care; health care consultancy services, namely, consultancy services in the field of medical care
Classe 45
Licensing of intellectual property rights; legal services related to the exploitation of intellectual property rights; enforcement of intellectual property rights by means of submitting copyright takedown notices for others; advisory services relating to intellectual property rights; legal research relating to intellectual property
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
05/10/2023
XXCR
GENERIC MADRID TRANSACTION CREATED
05/10/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/10/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/07/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
04/07/2023
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
30/05/2023
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
26/05/2023
GPNX
NOTIFICATION PROCESSED BY IB
24/04/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/04/2023
PUBO
PUBLISHED FOR OPPOSITION
11/04/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/04/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/04/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/03/2023
CHLD
CHANGE OF OWNER RECEIVED FROM IB
18/03/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/03/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
08/03/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/03/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
08/03/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/03/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
23/02/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
23/02/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
23/02/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
23/02/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/01/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/01/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/01/2023
RFNP
REFUSAL PROCESSED BY IB
23/08/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
15/08/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
29/07/2022
RFRR
REFUSAL PROCESSED BY MPU
28/07/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/07/2022
CNRT
NON-FINAL ACTION WRITTEN
06/07/2022
DOCK
ASSIGNED TO EXAMINER
15/06/2022
MAFR
APPLICATION FILING RECEIPT MAILED
02/04/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/03/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
14/03/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/03/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace THE PHARM BIO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.